Bulimia Nervosa News and Research

RSS

Bulimia nervosa is a type of eating disorder. It is often called just bulimia. A person with bulimia eats a lot of food in a short amount of time. This is called binging. The person may fear gaining weight after a binge. Binging also can cause feelings of shame and guilt. So, the person tries to "undo" the binge by getting rid of the food. This is called purging.

New drug naming system to be presented at ECNP conference in Berlin

What's in a name? Doctors have found that the name of the drug you are prescribed significantly influences how the patient sees the treatment.

20 Oct 2014

OCD diagnosis raises risk of subsequent schizophrenia

Patients who are diagnosed with obsessive–compulsive disorder are at increased risk of developing schizophrenia and schizophrenia spectrum disorders, a longitudinal study reports.

5 Sep 2014

Researchers observe link between eating disorders and several autoimmune diseases

Finnish researchers have observed an association between eating disorders and several autoimmune diseases with different genetic backgrounds. These findings support the link between immune-mediated mechanisms and development of eating disorders.

26 Aug 2014

Oral health: The gateway to your overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your oral health and your overall health.

25 Apr 2014

New textbook provides facts and dispels myths on sugar/fructose consumption

A new textbook, Fructose, High Fructose Corn Syrup, Sucrose and Health, published this month by Springer Press, under their Humana Press imprint, provides one of the most comprehensive scientific analyses on the closely-watched issue of caloric sweetener consumption.

1 Apr 2014

Study shows binge-eating disorder is associated with substantial lifelong impairments

Binge-eating disorder, designated in 2013 by the American Psychiatric Association as a diagnosis in its Diagnostic and Statistical Manual of Mental Disorders-V, is associated with substantial lifelong impairments comparable to those of bulimia nervosa, according to a recent World Health Organization study based on community epidemiological surveys conducted in 12 nations worldwide.

7 Jan 2014

Binge eating disorder is different from anorexia nervosa and bulimia nervosa

Food addiction is not yet recognised as a mental disorder but certain obese individuals clearly display addictive-like behaviour towards food.

9 Oct 2013

Two gene mutations associated with increased risk of developing eating disorders

Eating disorders like anorexia nervosa and bulimia often run in families, but identifying specific genes that increase a person's risk for these complex disorders has proved difficult.

9 Oct 2013

New treatment methods aim to help people reduce binge-eating behavior

Two new treatment methods under investigation at Drexel University aim to help people reduce binge-eating behavior.

30 Sep 2013

Study shows certain brain cells play critical role in anorexia, bulimia, and binge eating disorder

Sixty years ago scientists could electrically stimulate a region of a mouse's brain causing the mouse to eat, whether hungry or not. Now researchers from UNC School of Medicine have pinpointed the precise cellular connections responsible for triggering that behavior.

27 Sep 2013

Shadow of past highest weight affects eating disorder symptoms and recovery

Dieters and weight loss researchers are familiar with the principle: The more weight you've lost, the harder it is to keep it off. A complex and vicious cycle of biological and behavioral factors make it so.

25 Sep 2013

Researchers find genetic correlation between eating disorders and alcohol dependence

Part of the risk for alcohol dependence is genetic, and the same is true for eating disorders. Now, researchers at Washington University School of Medicine in St. Louis have found it's likely some of the same genes are involved in both.

21 Aug 2013

Altered function of neural circuitry contributes to bulimia and anorexia

Anorexia nervosa and bulimia nervosa -disorders characterized by extreme eating behavior and distorted body image - are among the deadliest of psychiatric disorders, with few proven effective treatments.

4 Jun 2013

Lightlake Therapeutics announces Phase II clinical trial results of nasal spray treatment for BED

Lightlake Therapeutics Inc., a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Company's Phase II clinical trial of its nasal spray treatment for Binge Eating Disorder were presented at the American Psychiatric Association Annual Meeting in San Francisco by Professor Hannu Alho, MD, professor of addiction medicine at the University of Helsinki and Principal Investigator for the trial.

23 May 2013

Research finds number of links between dental health and overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your dental health and your overall health.

23 May 2013

Study suggests that biology plays role in eating disorders

Female rats are much more likely to binge eat than male rats, according to new research that provides some of the strongest evidence yet that biology plays a role in eating disorders.

2 May 2013

New initiative launched to create more effective ED therapies based on brain imaging studies

Current treatments for anorexia and bulimia nervosa, which afflict an estimated 10 to 24 million Americans, are often limited and ineffective.

12 Apr 2013

New report addresses presence of cerebral abnormalities in eating disorders

A report from the University of Freiburg that is published in one of the last issue of Psychotherapy and Psychosomatics address the presence of cerebral abnormalities in eating disorders.

3 Apr 2013

Lightlake to present Phase II clinical trial results of opioid antagonist nasal spray at APA Annual Meeting

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing addiction treatments, announced today that a scientific abstract based on results of the Company's Phase II clinical trial of its opioid antagonist nasal spray treatment for patients with Binge Eating Disorder has been accepted for presentation at the American Psychiatric Association Annual Meeting taking place in San Francisco, California, May 18-22, 2013.

27 Mar 2013

APS to present scientific abstracts at Experimental Biology 2013

The American Physiological Society is one of six scientific societies sponsoring the meeting Experimental Biology 2013, being held April 20-24, 2013 at the Boston Convention and Exhibition Center, in Boston, Mass.

21 Mar 2013